Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
International Journal of Molecular Sciences
|
January 11, 2022
Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
Roberta Resaz, Davide Cangelosi, Daniela Segalerba, et al.
Journal for Immunotherapy of Cancer
|
April 2, 2021
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
Alessandra Dondero, Martina Morini, Davide Cangelosi, et al.
Open Biology
|
December 1, 2021
MYC regulates metabolism through vesicular transfer of glycolytic kinases
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 11, 2024
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate
Sandra Bibbò, Emily Capone, Giulio Lovato, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 17, 2025
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism
Teresa Maiorino, Marianna Avitabile, Vincenzo Aievola, et al.
Oncoimmunology
|
November 6, 2025
Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits
Chiara Vitale, Andrea Petretto, Katia Cortese, et al.
Cancers
|
October 3, 2019
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study
Martina Morini, Davide Cangelosi, Daniela Segalerba, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs
Veronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2021
Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Angela Bellini, Ulrike Pötschger, Virginie Bernard, et al.
JCO Precision Oncology
|
July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study
Hannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
International Journal of Molecular Sciences
|
January 11, 2022
Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
Roberta Resaz, Davide Cangelosi, Daniela Segalerba, et al.
Journal for Immunotherapy of Cancer
|
April 2, 2021
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
Alessandra Dondero, Martina Morini, Davide Cangelosi, et al.
Open Biology
|
December 1, 2021
MYC regulates metabolism through vesicular transfer of glycolytic kinases
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 11, 2024
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate
Sandra Bibbò, Emily Capone, Giulio Lovato, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 17, 2025
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism
Teresa Maiorino, Marianna Avitabile, Vincenzo Aievola, et al.
Oncoimmunology
|
November 6, 2025
Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits
Chiara Vitale, Andrea Petretto, Katia Cortese, et al.
Cancers
|
October 3, 2019
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study
Martina Morini, Davide Cangelosi, Daniela Segalerba, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs
Veronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2021
Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Angela Bellini, Ulrike Pötschger, Virginie Bernard, et al.
JCO Precision Oncology
|
July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study
Hannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Page
of 4